Intensity Therapeutics Inc. announced the publication in the journal OncoImmunology of results from nonclinical research conducted in partnership with NCI Vaccine Branch under a Cooperative Research and Development Agreement. All results and data reported in the paper were generated at the NCI.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
